The effects of caffeine intake on weight loss: a systematic review and dos-response meta-analysis of randomized controlled trials

被引:71
作者
Tabrizi, Reza [1 ]
Saneei, Parvane [2 ]
Lankarani, Kamran B. [3 ]
Akbari, Maryam [1 ]
Kolandooz, Fariba [4 ]
Esmaillzadeh, Ahmad [2 ,5 ]
Nadi-Ravandi, Somayyeh [6 ]
Mazoochi, Majid [7 ]
Asemi, Zatollah [8 ]
机构
[1] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Inst Hlth, Student Res Comm, Shiraz, Iran
[2] Isfahan Univ Med Sci, Food Secur Res Ctr, Dept Community Nutr, Sch Nutr & Food Sci, Esfahan, Iran
[3] Shiraz Univ Med Sci, Hlth Policy Res Ctr, Shiraz, Iran
[4] Univ Alberta, Dept Med, Indigenous & Global Hlth Res, Edmonton, AB, Canada
[5] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran
[6] Kashan Univ Med Sci, Hlth Informat Management Res Ctr, Kashan, Iran
[7] Kashan Univ Med Sci, Sch Med, Dept Cardiol, Kashan, Iran
[8] Kashan Univ Med Sci, Res Ctr Biochem & Nutr Metab Dis, Kashan, Iran
关键词
Caffeine; weight loss; meta-analysis; HORMONE BINDING GLOBULIN; DOUBLE-BLIND; ENERGY-EXPENDITURE; GLUCOSE-TOLERANCE; OBESE WOMEN; BODY-MASS; INSULIN; OVERWEIGHT; ADENOSINE; EXERCISE;
D O I
10.1080/10408398.2018.1507996
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
This systematic review and meta-analysis of randomized controlled trials (RCTs) was performed to summarize the effect of caffeine intake on weight loss. We searched the following databases until November 2017: MEDLINE, EMBASE, Web of Science, and Cochrane Central Register of Controlled Trials. The relevant data were extracted and assessed for quality of the studies according to the Cochrane risk of bias tool. We estimated an intake-status regression coefficient (Beta) for each primary study and estimated the overall pooled Beta and SE using random effects meta-analysis on a double-log scale. Heterogeneity between studies was assessed by the Cochran Q statistic and I-squared tests (I-2). Thirteen RCTs with 606 participants were included in the meta-analyses. The overall pooled Beta for the effect of caffeine intake was 0.29 (95%CI: 0.19, 0.40; Q = 124.5, I-2 = 91.2%) for weigh, 0.23 (95%CI: 0.09, 0.36; Q = 71.0, I-2 = 93.0%) for BMI, and 0.36 (95% CI: 0.24, 0.48; Q = 167.36, I-2 = 94.0%) for fat mass. For every doubling in caffeine intake, the mean reduction in weight, BMI, and fat mass increased 2 Beta-fold (20.29 = 1.22, 20.23 = 1.17, and 20.36 = 1.28), which corresponding to 22, 17, and 28 percent, respectively. Overall, the current meta-analysis demonstrated that caffeine intake might promote weight, BMI and body fat reduction.
引用
收藏
页码:2688 / 2696
页数:9
相关论文
共 38 条
[1]   Thermogenic drugs as a strategy for treatment of obesity [J].
Astrup, A .
ENDOCRINE, 2000, 13 (02) :207-212
[2]   CAFFEINE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ITS THERMOGENIC, METABOLIC, AND CARDIOVASCULAR EFFECTS IN HEALTHY-VOLUNTEERS [J].
ASTRUP, A ;
TOUBRO, S ;
CANNON, S ;
HEIN, P ;
BREUM, L ;
MADSEN, J .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1990, 51 (05) :759-767
[3]   Antioxidant-rich coffee reduces DNA damage, elevates glutathione status and contributes to weight control: Results from an intervention study [J].
Bakuradze, Tamara ;
Boehm, Nadine ;
Janzowski, Christine ;
Lang, Roman ;
Hofmann, Thomas ;
Stockis, Jean-Pierre ;
Albert, Franz W. ;
Stiebitz, Herbert ;
Bytof, Gerhard ;
Lantz, Ingo ;
Baum, Matthias ;
Eisenbrand, Gerhard .
MOLECULAR NUTRITION & FOOD RESEARCH, 2011, 55 (05) :793-797
[4]   Herbal ephedra/caffeine for weight loss: a 6-month randomized safety and efficacy trial [J].
Boozer, CN ;
Daly, PA ;
Homel, P ;
Solomon, JL ;
Blanchard, D ;
Nasser, JA ;
Strauss, R ;
Meredith, T .
INTERNATIONAL JOURNAL OF OBESITY, 2002, 26 (05) :593-604
[5]   Muscle Uncoupling Protein 3 Expression Is Unchanged by Chronic Ephedrine/Caffeine Treatment: Results of a Double Blind, Randomised Clinical Trial in Morbidly Obese Females [J].
Bracale, Renata ;
Petroni, Maria Letizia ;
Davinelli, Sergio ;
Bracale, Umberto ;
Scapagnini, Giovanni ;
Carruba, Michele O. ;
Nisoli, Enzo .
PLOS ONE, 2014, 9 (06)
[6]   A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment [J].
Coffey, CS ;
Steiner, D ;
Baker, BA ;
Allison, DB .
INTERNATIONAL JOURNAL OF OBESITY, 2004, 28 (11) :1411-1419
[7]   Effects of Citrus aurantium extract, caffeine, and St. John's Wort on body fat loss, lipid levels, and mood states in overweight healthy adults [J].
Colker, CM ;
Kalman, DS ;
Torina, GC ;
Perlis, T ;
Street, C .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1999, 60 (03) :145-153
[8]  
Davoodi SH, 2014, IRAN J PHARM RES, V13, P707
[9]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[10]   NORMAL CAFFEINE CONSUMPTION - INFLUENCE ON THERMOGENESIS AND DAILY ENERGY-EXPENDITURE IN LEAN AND POSTOBESE HUMAN VOLUNTEERS [J].
DULLOO, AG ;
GEISSLER, CA ;
HORTON, T ;
COLLINS, A ;
MILLER, DS .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1989, 49 (01) :44-50